You searched for "conjunctivae"

609 results found

Resection versus advancement for consecutive XT

The authors performed a retrospective review of results for patients treated with resection for consecutive exotropia in comparison to patients treated with advancement to the original insertion. The age of the resection and advancement groups averaged 33.6 and 38.2 years...

Modification of surgery to reduce consecutive ET

Surgical treatment for recurrent exotropia (ET) predominantly depends on the primary surgery. Modification of surgical dose may be required in secondary procedures. The aim of this study was to compare surgical outcomes of modified and conventional secondary surgery using lateral...

DVD angle measurements

Surgical treatment for recurrent exotropia (ET) predominantly depends on the primary surgery. Modification of surgical dose may be required in secondary procedures. The aim of this study was to compare surgical outcomes of modified and conventional secondary surgery using lateral...

Surgical treatment outcomes and predictors for consecutive exotropia

This retrospective study presented the long-term results of consecutive exotropia surgery and its prognostic factors, and compared efficacy of medial rectus advancement, lateral rectus recession, or a combination of both. Patients were treated between 2000–2020. Mean age was 33.98 ±17.68...

Traumatic ‘toy’ gun injury leading to permanent vision loss

Pseudoxanthoma elasticum (PXE) is a progressive, inherited disorder of connective tissue that affects the skin, cardiovascular system and retina. Ocular manifestations of the disease are related to Bruch’s membrane, a thin elastic tissue layer located between the retinal pigment epithelium...

The madarosis mystery: unravelling the clues to a host of health issues

Eyelash madarosis is a medical condition characterised by the loss of eyelashes caused by the destruction of hair follicles. It can range from a few missing lashes to a complete absence of lashes on the eyelids. This condition can be...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

External dacryocystorhinostomy in the management of childhood epiphora

Congenital nasolacrimal duct obstruction is thought to be caused by a membranous obstruction at the distal end of the nasolacrimal duct (NLD). Rarely, associated midline deformities in soft tissue and bony structures of the face are present in patients with...

Management of DMO and PDR in 2019

An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...

Optegra launches new fellowship programme

Leading eye health care group, Optegra, is proud to announce the appointment of its first Fellow, Mr Fadi Alfaqawi, as it unveils its Cataract and Refractive Surgery Fellowship Programme.

SpaMedica extends its ophthalmic training programme, creating vital placements for NHS registrars

The UK’s largest provider of NHS cataract surgery is already supporting 60 aspiring surgeons, and has recently appointed three staff members to further develop its training provision.

Blind Inverclyde woman finds her voice

Claire Forde (29) from Greenock is no stranger to a microphone. Her journey into public speaking took a major step forward this year when she joined a newly launched Speakers Club, created to improve the confidence and communication skills of...